RISPERIDONE 2 mg STRIDES TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

risperidone 2 mg strides tablet

strides pharma (sa) (pty) ltd - tablet - see ingredients - each tablet contains risperidone 2,0 mg

METFORMIN 1 000 STRIDES TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

metformin 1 000 strides tablet

strides pharma (sa) (pty) ltd - tablet - see ingredients - each tablet contains metformin hydrochloride 1000,0 mg

ZODORAY 1 ug CAPSULES South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

zodoray 1 ug capsules

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains alfacalcidol 1,0 ug

ZODORAY 0,5 ug CAPSULES South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

zodoray 0,5 ug capsules

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains alfacalcidol 0,5 ug

ZODORAY 0,25 ug CAPSULES South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

zodoray 0,25 ug capsules

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains alfacalcidol 0,25 ug

CALCILOS 1 ug CAPSULES South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

calcilos 1 ug capsules

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains alfacalcidol 1,0 ug

CALCILOS 0,5 ug CAPSULES South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

calcilos 0,5 ug capsules

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains alfacalcidol 0,5 ug

CALCILOS 0,25 ug CAPSULES South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

calcilos 0,25 ug capsules

strides pharma (sa) (pty) ltd - capsules - see ingredients - each capsule contains alfacalcidol 0,25 ug

NEVIRAPINE tablet United States - English - NLM (National Library of Medicine)

nevirapine tablet

strides pharma science limited - nevirapine (unii: 99dk7fvk1h) (nevirapine - unii:99dk7fvk1h) - nevirapine 200 mg - nevirapine tablets, usp is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection in adults and pediatric patients 15 days and older [see clinical studies (14.1, 14.2)] . limitations of use: based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine tablets, usp is not recommended to be initiated, unless the benefit outweighs the risk, in: -   adult females with cd4+ cell counts greater than 250 cells/mm3 or -   adult males with cd4+ cell counts greater than 400 cells/mm3 [see warnings and precautions (5.1)] . nevirapine tablets, usp are contraindicated: - in patients with moderate or severe (child-pugh class b or c, respectively) hepatic impairment [see warnings and precautions (5.1) and use in specific populations (8.7)] - for use as part of occupational and non-occupational post-exposure prophylaxis (pep) regimens [see warnings and precautions (5.1)] . pregnancy exposure registry th